Article
Cerium Oxide Nanoparticles Regulate Insulin Sensitivity and Oxidative Markers in 3T3-L1…
Oxidative Medicine and Cellular Longevity · 2018 · Amaya Lopez-Pascual, author Andoni Urrutia-Sarratea, author Silvia Lorente-Cebrián, author J. Alfredo Martinez, author Pedro González-Muniesa, author Giulio Ceolotto, Academic Editor
Key facts
| Title | Cerium Oxide Nanoparticles Regulate Insulin Sensitivity and Oxidative Markers in 3T3-L1 Adipocytes and C2C12 Myotubes |
|---|---|
| First author | Amaya Lopez-Pascual, author Andoni Urrutia-Sarratea, author Silvia Lorente-Cebrián, author J. Alfredo Martinez, author Pedro González-Muniesa, author Giulio Ceolotto, Academic Editor |
| Journal | Oxidative Medicine and Cellular Longevity |
| Published | Jun 21, 2018 |
| DOI | 10.1155/2019/2695289 |
| Devices mentioned | BK110039, DEN000008, K022086, K103302, K982529 |
| Product codes mentioned | JCI, JIT, JJX, JJY, KIT, MRR, NDS, NJT, OOI, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1